Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wilhelm

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Onkologie|June 9, 2012
[Proposals for the advancement of certification]Martin Wilhelm
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 6, 2019
[Durvalumab after chemoradiotherapy is currently the most promising treatment for stage III NSCLC]Martin Wilhelm
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 26, 2017
[Overweight and obesity are risk factors for development of cardiotoxicity from anthracyclines or sequential administration of anthracyclines and trastuzumab]Martin Wilhelm
The Lancet. Oncology|October 5, 2011
Adjuvant zoledronic acid for breast cancer: mechanism of action?Volker Kunzmann, Martin Wilhelm
Leukemia & Lymphoma|July 16, 2005
Anti-lymphoma effect of gammadelta T cellsVolker Kunzmann, Martin Wilhelm
Onkologie|September 12, 2012
[Model projects in integrated oncology]Gustav Dobos, Martin Wilhelm
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 14, 2020
[Relationship between prior antibiotic treatment and response to immune checkpoint inhibitor therapy and survival in patients with cancer]Anna Bauereiß, Martin Wilhelm
Brain Pathology (Zurich, Switzerland)|June 5, 2010
The epidemiology of dementia associated with Parkinson's diseaseDag Aarsland, Martin Wilhelm Kurz
Journal of the Neurological Sciences|September 8, 2009
The epidemiology of dementia associated with Parkinson diseaseDag Aarsland, Martin Wilhelm Kurz
Clinical Lymphoma & Myeloma|April 28, 2006
The role of high-dose therapy in peripheral T-cell lymphomasPeter Reimer, Thomas Rüdiger, Martin Wilhelm
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Onkologie|June 9, 2012
[Proposals for the advancement of certification]Martin Wilhelm
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 6, 2019
[Durvalumab after chemoradiotherapy is currently the most promising treatment for stage III NSCLC]Martin Wilhelm
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 26, 2017
[Overweight and obesity are risk factors for development of cardiotoxicity from anthracyclines or sequential administration of anthracyclines and trastuzumab]Martin Wilhelm
The Lancet. Oncology|October 5, 2011
Adjuvant zoledronic acid for breast cancer: mechanism of action?Volker Kunzmann, Martin Wilhelm
Leukemia & Lymphoma|July 16, 2005
Anti-lymphoma effect of gammadelta T cellsVolker Kunzmann, Martin Wilhelm
Onkologie|September 12, 2012
[Model projects in integrated oncology]Gustav Dobos, Martin Wilhelm
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 14, 2020
[Relationship between prior antibiotic treatment and response to immune checkpoint inhibitor therapy and survival in patients with cancer]Anna Bauereiß, Martin Wilhelm
Brain Pathology (Zurich, Switzerland)|June 5, 2010
The epidemiology of dementia associated with Parkinson's diseaseDag Aarsland, Martin Wilhelm Kurz
Journal of the Neurological Sciences|September 8, 2009
The epidemiology of dementia associated with Parkinson diseaseDag Aarsland, Martin Wilhelm Kurz
Clinical Lymphoma & Myeloma|April 28, 2006
The role of high-dose therapy in peripheral T-cell lymphomasPeter Reimer, Thomas Rüdiger, Martin Wilhelm
Pageof 10